Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
Palivizumab prophylaxis not routinely recommended; may consider<sup>10</sup> if <12 mo old and w/ CLD and/or nutritional compromise, or in 2nd yr of life if manifestations of severe lung dz<sup>11</sup> or weight for length <10th percentile
By
vgreene
, 24 December, 2014
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube